Pharma News

Study Finds Parkinson Disease Drug Nearly Matches Wegovy in Weight Loss Effects

Early-stage trial results indicate that NLRP3 inflammasome inhibitors were able to achieve nearly the same weight loss as Wegovy while also reducing inflammatory biomarkers linked to heart disease.

Source link
#Study #Finds #Parkinson #Disease #Drug #Matches #Wegovy #Weight #Loss #Effects

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *